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  The world, in fact, is only beginning to see that the wealth of a nation consists 
more than anything else in the number of superior men that it harbors .... Geniuses are 
ferments; and when they come together, as they have done in certain lands at certain 
times, the whole population seems to share in the higher energy which they awaken. The 
effects are incalculable and often not easy to trace in detail, but they are pervasive and 
momentous. 
     -  William  James  (1911,  p.  363) 
 
In the last half of the twentieth century, America was the location of choice for the best 
and brightest scientific minds in the world.  Recently America has partially rolled up its welcome 
mat to foreign doctoral and postdoctoral students while a reverse brain drain has set in for senior 
professors.  Does this matter for the US economy or is it a matter of purely academic concern – 
in both senses?  This paper reports evidence that a sizable fraction of the very top scientists are 
responsible for startup firms across the broad range of high-technology industries whether they 
are in the United States or abroad.  When America loses its star scientists – or star scientists in 
the making – it is losing not only their academic research and teaching, but new firms and jobs. 
On the order of one third of the star scientists actually become involved in 
commercializing their discoveries at least once in their career; so losing a few hundred star 
scientists will have a small effect on the number of firms started in the US over the next 
generation.  However, the firms started with star scientists as principals have proven to be the 
leading firms in terms of innovation and employment growth in a number of high-technology 
industries, such as biotechnology, lasers and semiconductors.  In America and similar 
economies, most economic growth is concentrated at any given time in a relatively few firms in a 
relatively few industries experiencing very large productivity gains or introducing new products 
of much greater value than their cost of production (Harberger 1998, Darby and Zucker 2003).   
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These firms are most often but not always somewhere en route from entrepreneurial start-up to 
large, industry-dominant firms.
1  Losing to other countries star scientists who are likely to 
become star innovators is a recipe for shifting leading firms in specific new technologies abroad, 
leaving an imitative or no role for American firms. 
This paper is organized in four sections.  The first section discusses research findings in 
the literature on university-industry technology transfer before focusing on our research on the 
role of star scientists in determining where and when firms enter the biotechnology industry, 
which firms are most successful, how quickly they go public, and the stock market returns for 
particular firms.  Section II presents evidence that – at least so far as starting firms is concerned – 
these top scientists are star innovators across the gamut of high-tech industries.  Section III 
presents evidence on the emergence of a reverse brain drain from the US to other countries that 
has reduced the number of these top scientists operating in and starting firms in the US.  The 
final section offers conclusions and concerns for policymakers. 
 
I. Top Scientists as Star Innovators 
The importance of basic university science to successful commercialization of scientific 
discoveries has been confirmed in a number of other research studies, especially the importance of 
intellectual human capital (Di Gregorio and Shane 2003).  Faculty are a key resource in creating and 
transferring early, discovery research via commercial entrepreneurial behavior (Yarkin 2000).   
Jensen and Thursby (2001) confirm that active, self-interested participation of discovering 
professors is an essential condition for successful commercial licensing of most university 
inventions.  Thursby and Thursby (2002) find that the sharp increase in university-industry 
technology transfer has not resulted so much from a shift in the nature of faculty research as from an  
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increased willingness of faculty and administrators to license and increased interest on the part of 
firms. 
Labor mobility of discovering scientists becomes very important in technology transfer, 
however, when a new discovery has both high commercial value and a combination of scarcity 
and tacitness that defines natural excludability, the degree to which there is a barrier to the flow 
of the valuable knowledge from the discoverers to other scientists (Zucker and Darby 1996b; 
Zucker, Darby and Brewer 1998).  Those with the most information about breakthrough 
discoveries are the scientists actually making them, so there is initial scarcity. 
To the extent that the knowledge is both scarce and tacit, as it often is in breakthrough 
discoveries, it constitutes intellectual human capital retained by the discovering scientists and is 
embodied in them.  At the extreme, labor mobility is required to transfer the knowledge 
successfully (as found empirically by Jensen and Thursby 2001).  To measure the extent of labor 
mobility of the stars, we use the count of ‘linked’ articles authored by stars with firm employees.  
These linked stars are most often local academic scientists-entrepreneurs who possess a 
significant equity or founding interest in the firm.  The number of such articles serves as an 
indicator of the depth of the star’s involvement with the firm’s research effort.  Nearly 70 percent 
of the ISI highly cited stars, who are the focus of Sections II and III, write at least one article 
with at least one firm employee, with 10 percent of all articles written by these stars linked to a 
firm. 
In order to gain access to the knowledge of discovering scientists, firms in related areas 
of technology employ them.  In most cases, the discovering scientists are initially employed by 
universities and research institutes; we are concerned with the extent to which they move at least 
part of their labor effort to specific firms.  Some of these firms are incumbent firms which adopt  
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the new technology (see Zucker and Darby 1996a, 1996b, 1997a, 1997b, Darby and Zucker 
2001), but many of the firms are newly created around these star scientists, who often become 
residual owners as well as employees (Zucker, Darby and Brewer 1998).  The discovering 
scientists often become the main resource around which firms are built or transformed (Zucker, 
Darby and Brewer 1998, Zucker, Darby and Armstrong 1998 and 2002; Darby and Zucker 2007; 
Zucker and Darby 2006).  Star scientists are important in the process of technology transfer 
because the knowledge is both scarce and tacit and because their knowledge contributes 
significantly to the success of firms (Zucker, Darby and Torero 2002). 
Our biotechnology database and research program was built around the 327 most productive 
scientists in terms of genetic sequence discoveries through 1989, a period encompassing the 
formative years of biotechnology but ending before the advent of automated sequencers which 
made our selection criterion obsolete in the 1990s.  These ‘star’ scientists are truly among the best 
and brightest in the world:  Accounting for only 0.7 percent of the authors of articles reporting 
genetic sequence discoveries through 1989, they accounted for 17.3 percent of the published 
articles.  Great scientists – including these stars – differ from ordinary scientists in many ways, from 
mentoring fewer and brighter students to many more articles published, citations to those articles 
and patents (Zuckerman 1967, 1977; Zucker, Darby and Armstrong 1998).  Not only did these 
scientists play a major role in shaping the advance of the science underlying biotechnology, our 
research has also shown that they played an important role in determining where and when firms 
entered biotechnology and which of those firms were most successful. 
Zucker, Darby and Brewer (1998) and Darby and Zucker (2001) examined entry of new 
firms and incumbent firms into biotechnology in America and Japan, respectively.  We argue there 
that the geographic distribution of a new science-based industry can be mostly derived from the  
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geographic distribution of the intellectual human capital embodying the breakthrough discovery 
upon which it is based.  This occurs when the discovery – especially an ‘invention of a method of 
discovery’ (Griliches 1957) – is sufficiently costly to transfer due to its uncodified complexity or 
tacitness (Nelson 1959; Arrow 1962, 1974; Nelson and Winter 1982; Rosenberg 1982) that the 
information can effectively be used only by employing those scientists in whom it is embodied.  
Technological opportunity and appropriability – the principal factors that drive technical progress 
for industries (Nelson and Wolff 1997; Klevorick, Levin, Nelson and Winter 1995) – are also the 
two necessary elements that created extraordinary value for our stars' intellectual human capital 
during the formative period of biotechnology.  The employment of stars with a firm was often as a 
founding principal and usually part-time near their university laboratory (Zucker, Darby and 
Armstrong 1998; Zucker, Darby and Torero 2002).  When the new techniques have diffused widely, 
access to stars is less essential, but once the technology has been commercialized in specific locales, 
internal dynamics of agglomeration tend to keep it there (Grossman and Helpman 1991; Marshall 
1920; Audretsch and Feldman 1993, 1996; Head, Ries and Swenson 1995).
2 
In both the US and Japan, where and when star scientists are active has a strongly positive 
and significant independent effect on where and when biotech-using firms entered into 
biotechnology, and this effect is always separate from, and in addition to, the effects of research 
support for university scientists and local general economic conditions.  We do find that intellectual 
capital variables play a relatively more important role for entry in the US whereas it is the local 
economic geography variables which are more significant in Japan. 
As far as we know, neither we nor any other scholars have done any comparable research 
for Europe for this formative period through 1990.  To a large degree, this may reflect a real 
disconnection during this period between academic science and industry.  We recall a German  
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pharmaceutical executive complaining, as late as the early 1990’s, that the only way his firm could 
get German scientists to do genetic engineering for them was to employ them in the United States.  
A series of papers by Cooke (2001, 2004 and 2005) suggests that disconnection has since been 
bridged in some European metropolitan regions. 
Table 1, adapted from Zucker and Darby (1999b), shows that Europe in fact had enough of 
the world’s star scientists during the formative period to have been a major player in the commercial 
biotechnology revolution rather than playing the peripheral role that it did.  Europe, including 
Russia and Israel, accounted for 32 percent of the stars, counted once per nation in which they 
published, compared to 62 percent for the US and Japan.  The European university-industry 
disconnection is underlined by the fact that the corresponding percentages for stars ever working as 
or with a firm employee are 9 and 90.  Small net immigration into a few countries did not offset the 
large emigration from Britain and Switzerland to the benefit of the US and Japan.  Anecdotal 
evidence suggests that the greater hospitality of the latter countries to academic scientist-
entrepreneurs played a role in this pattern with immigrants establishing firm ties soon after moving.  
We hypothesize in Section III on the reasons that the virtuous circles present in America and Japan 
may have been largely short-circuited in Europe. 
We have found that the publication of articles by a star as, or with, a firm employee is a 
robust indicator of substantial involvement of that star with the firm.  Substantial involvement of 
one or more star bioscientists was not a sufficient condition to make a firm successful, but it 
dramatically improved the odds relative to those firms that did not have it.  For example, we 
consider the 38 publicly traded 1975 members of the Pharmaceutical Manufacturers Association.  
Of the 15 firms which developed working arrangements with star scientists by 1990, 80 percent (12 
firms) survived until 1999.  Of the 23 firms without such star participation, only 17.4 percent (4  
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firms) survived to 1999 (Darby and Zucker 2001).  A pharmaceutical firm not doing cutting edge 
biotechnology by the 1990s was either going out of business or into generics or other businesses. 
In Zucker, Darby and Armstrong (1998) we analyzed the success of a census of Californian 
biotech firms in terms of number of products in development, number of products on the market and 
employment growth.  We demonstrated that what appear to be ‘geographically localized knowledge 
spillovers’ (positive externalities as proposed by Jaffe 1986; Jaffe, Trajtenberg and Henderson 
1993) from academic science to research productivity of nearby firms were in fact concentrated in 
the relatively few firms with stars linked via co-authorship whereas other firms gained no advantage 
from locating near the leading research universities.
3  These results were obtained from poisson 
regressions which controlled for the effect of firm characteristics such as incumbency-new-entrant 
status, technology used and time since entry.  The estimated effects are quite significant as indicated 
in the left side of Figure 1.  The more star-linked articles a firm had – indicating deeper involvement 
of the star at the bench level – the better the firm did, whether judged by products in development, 
products on the market or employment.  These differences are large enough to explain the 
difference between success and failure:  A biotech firm with no star-linked articles (with all other 
factors set to their mean values) had an expected employment growth of 80 workers from 1984 to 
1989 compared to 341 and 734 for firms with 2 and 5 articles, respectively. 
We replicated these results for Japan in Zucker and Darby (2001), with the star impacts 
indicated on the right half of Figure 1.  There are two notable differences from the California 
results: Firstly, the entire profile of products on the market in Japan is much lower and flatter, as 
they were lagging behind California by approximately 5 years.  Secondly, we were unable to get 
usable estimates of biotechnology employment for Japanese firms which were almost exclusively 
large incumbent firms using the technologies in a limited sector of their businesses.  As a result we  
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substituted the number of US patents granted as a third measure of success and found results that fit 
the pattern of strong effects from star involvement. 
There is much more evidence that the star scientists play a special role, independently from 
their potentially separable research discoveries, in shaping the formation and transformation of 
biotechnology-using industries.  Figure 2 (adapted from Zucker, Darby and Armstrong 2002, Figure 
2) illustrates that star articles are a much stronger indicator of firm success than popular alternatives 
such as all firm articles co-authored with top-research-university faculty members or venture capital 
funding.  Audretsch and Stephan (1996) had analyzed the locational patterns of university scientists 
appearing in the prospectuses of biotechnology firms going public March 1990 and November 
1992, many of whom overlapped with our set of stars.  In Darby and Zucker (2007) we show that 
firms with deeper star involvement do go public significantly more quickly than other biotech firms; 
implying that the characteristics described by Audretsch and Stephan differed systematically from 
the entire population of private biotech firms at risk for going public.  Darby, Liu and Zucker (2004) 
show that not only does the stock market value star involvement in pricing publicly traded biotech 
firms, but those firms follow different high risk, high return strategies reflected in larger jumps or 
discontinuities in the evolution of their stock prices.  Zucker and Darby (2007a) show that the stars’ 
contributions to open science increase during their period of involvement with a firm, so that both 
science and commerce profit in the mutually reinforcing ‘virtuous circle’ alluded to previously.
4 
In short, direct involvement of the very best academic scientists in commercialization of 
cutting-edge discoveries is a key determinant of which firms will win the competitive race and 
which will fall by the wayside.  In high-technology, the race most often goes to the smartest. 
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II. Top Scientists and Entry of High-Technology Firms 
We are beginning to investigate whether or not top scientists provide important top 
innovators across the gamut of high-technology industries, or whether this is a characteristic only 
of scientific areas undergoing very rapid change, like biotechnology and nanotechnology.  We 
report here on the results for whether or not the presence of top scientists in a region or country 
generally lead to more entry there of firms in related technologies.  Complete details of the 
statistical procedures, data, and results can be found in Zucker and Darby (2006). 
II.A. Data 
This project is challenging because data are difficult and costly to obtain and far from 
perfect for investigating entrepreneurial companies, particularly in the formative years of a new 
technology when most of the firms are not publicly traded and hence not required to make public 
disclosures.  The entry of high-technology firms into a technology can be approximately dated 
from the date of their first patent application or scientific-article publication.  For NanoBank.org, 
we developed as complete as possible a list of companies using nanotechnology (Zucker and 
Darby 2007b; Zucker, Darby, Furner, Liu and Ma 2007).  We verified that substituting entry 
dates for those firms gave us essentially the same results as we obtained using the patenting-
publication method of identifying firms. 
We examine the pattern of firm entry for six science and technology areas (Biology, 
Chemistry & Medicine; Computing & Information Technology; Semiconductors, Integrated 
Circuits & Superconductors; Nanoscale Science & Technology; Other Sciences; and Other 
Engineering).  The five areas other than nanotechnology were developed for and detailed in 
analyses reported in Darby and Zucker (1999) and Zucker and Darby (1999a) that span scientific 
articles, patents, and university doctoral-programs data from the National Research Council  
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(1995).  We were unable to find finer breakdowns that did not require data in greater detail in 
one or more of these sources.  Under National Science Foundation funding, we are developing a 
public digital database Nanobank.org which permits us to extract specific articles and patents for 
nanotechnology from the other five areas in which they would otherwise appear.  See Zucker, 
Darby, Furner. Liu and Ma (2007) for a discussion of the methodology used to define 
nanotechnology articles and patents.  Geographic units are alternatively the 179 US functional 
economic regions or the 25 top science and technology countries in the world in terms of 
patenting and publication.
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Another data challenge has been identifying star scientists across the broad range of 
scientific and engineering disciplines.  In our previous research, we have identified the stars 
using measures of scientific productivity uniquely tailored to the particular science area and 
independent of their direct involvement in the commercialization of their discoveries.  In order to 
generalize the star concept, we needed to find a criterion of scientific productivity which was 
comparable across fields and not dependent on whether or not the star was actually involved in 
commercialization.  (Since we are investigating star scientists who do commercialize their 
inventions, we need to define top scientists independent of that involvement.)   
The Institute for Scientific Information
®, Inc. (ISI
®) has developed the ISI Highly Cited 
component of the ISI Web of Science
® which is very close to what is needed.  The ISI 
HighlyCited.com website (Institute for Scientific Information 2005b) offers a database of the top 
250 individual researchers in terms of 20-year-rolling-window citation counts in each of 21 
subject fields – 19 of which are science and engineering fields.  Information for each highly cited 
author includes a curriculum vitae (usually full but sometimes abbreviated
6), a list of 
publications taken from the author’s curriculum vitae, and links for those publications in ISI- 
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listed journals to the full bibliographic information indexed in the ISI Web of Science
® (Institute 
for Scientific Information 1981-1997, 2005a).  Altogether we thus identify 5,401 star scientists, 
one or more of who are credited with authorship of some 520,839 articles that appear in the ISI 
Web of Science
® database.  The articles are used to identify where the stars are active based on 
those 299,583 cases (52.5 percent of the appearances of stars as authors) where their affiliation is 
unambiguous.
7  We have used these addresses to identify each US region or non-US country in 
which these star scientists were active 1981-2004.  We code the stars as active in a region from 
two years before their first publication there until they move to another location.  During 
transitional phases they are coded as active for up to two years in both locations.  Stars who 
maintain long-term affiliations in multiple countries also are coded as active in each location. 
II.B. Empirical Results 
Figures 3 and 4, taken from Zucker and Darby (2006), illustrate the relationship between 
stars ever active and cumulative firm entry 1981-2004 for US regions for the largest science and 
technology area (biology-chemistry-medicine) and the newest (nanoscale science & technology), 
respectively.  In each case there is a high correlation between the number of star scientists and 
the number of firms that have entered the corresponding area of science and technology.   
However, the actual number of stars is much smaller relative to the number of new firms in the 
nanoscale S&T area than in the biology-chemistry-medicine area.  We believe that this 
difference reflects the speed with which discoveries with nanotechnology application are being 
commercialized versus the slowness of recognition of star scientists in this new multidisciplinary 
area based on counts of citations to their work relative to other publications in the same pre-
existing discipline as the journals in which most of an author’s articles appear.  
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Figures 5 and 6, also taken from Zucker and Darby (2006), illustrate the relationship 
between stars ever active and cumulative firm entry 1981-2004 for the top-25 science and 
technology countries in the world for the same two science and technology areas as Figures 3 
and 4.  The pattern is strikingly similar to what was seen for US regions.  It would take literally 
hundreds of maps to cover all six science and technology areas for entry and star presence each 
year at the US regional level and nationally.  Furthermore, maps cannot adequately account for 
other variables which may account for the correlation.  In Zucker and Darby (2006) we have 
used advanced statistical methods to simultaneously take account of other measures of scientific 
base and economic geography.  We were particularly concerned with including measures of the 
actual discoveries in a region (patents, highly-cited articles, other articles) to distinguish the 
effect of the stars personally from that of their discoveries. 
The statistical results are clear:  Holding other measures of scientific base and economic 
geography constant, regions or countries with more of these top scientists present in one of the 
six S&T areas also exhibit a significantly higher rate of firm entry in that S&T area.  The effects 
are quite large in magnitude as illustrated in Figure 7, adapted from Zucker and Darby (2006).  
The left half of the figure refers to estimates based on data for US regions for each year, 1981-
2004.  The right half of the figure refers to estimates based on the 24 non-US countries among 
the top 25 S&T countries in the world.  Separate estimates on the effects of star scientists on the 
rate of firm entry by region per year and by country per year are obtained for each of the 6 S&T 
areas which are abbreviated at the bottom of the horizontal axis.  The height of the bar indicates 
the predicted rate of entry for a particular assumed number of stars in the region or country given 
that all the other determinants are at their mean values relative to the same rate if the number of 
stars was also equal to its mean value.  The first bar in the quartet for a given S&T area gives the  
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relative probability assuming there is one star scientist in the S&T area & region/country a given 
year.  The second bar – always equal to 1 – is the relative ratio if the assumed number of stars 
equals the mean value.  The third and fourth bars increase the number of stars above the mean by 
one and by two standard deviations, respectively.  The associated increase in the rate of firm 
entry is substantial – in several cases astonishing so – for all cases except for the anomalous 
negative effect for Other Sciences in the top-24 non-US S&T countries.  That anomalous case, 
semiconductors for both samples and computing/IT for the US case are not statistically 
significantly different from zero, but all the other estimates are significantly positive.  If we 
consider the estimates – not illustrated in Figure 7 – for all top-25 S&T countries (including the 
US) then entry has a significant positive impact in every case.  However, since the data may 
impart a US-centric bias and since the much higher number of stars in the US than in any of the 
other countries may pick up any institutional advantages for entrepreneurial entry, we will not 
consider those estimates further. 
We have conducted various experiments to test the robustness of the results.  One set of 
questions concerns our use of the date of the first patent application or scientific-article 
publication in a region/country and S&T area to measure the entry date of high-technology firms 
in that place and technology area.  We do it because there is generally no alternative.  However, 
for NanoBank.org, we developed as complete as possible a list of companies using 
nanotechnology using industry directories, web searches and other archival sources (Zucker and 
Darby 2007b).  We verified that substituting entry dates for those firms gave us essentially the 
same results as we obtained using the patenting-publication method of identifying firms. 
Another concern was that the ISI Highly Cited numbers were large relative to previously 
used techniques for identifying star scientists in particular technology areas.  We restricted our  
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list of stars to the first third reported in ISI – roughly the top 100 in each of the 19 science and 
engineering fields – and obtained slightly improved results illustrated in Figure 8, drawn from 
results reported in Tables A.2 and A.4 in Zucker and Darby (2006).  The headline results are 
very similar to those in Figure 7, but this is surprising unless the impact of the remaining stars is 
higher than those whose information we have discarded from the statistical analysis. 
These results are only a first step in demonstrating that the very best and brightest 
scientists frequently become involved in commercializing their discoveries, often as a founder or 
cofounder of an entrepreneurial firm.  We believe that it is a large first step in the direction of 
showing that these extraordinary individuals play a role in innovation and growth across the full 
spectrum of high technology industries. 
 
III. Emergence and Migration of Top Scientists 
Given the right institutional conditions, a significant fraction of star scientists become 
star innovators who drive growth and progress via creating and transforming high-technology 
industries, usually while continuing to make major contributions to science.  These individuals 
are true geniuses in the original sense – not just having extraordinary intelligence and 
transcendent creativity but actively using it to transform their world and ours.  Finding time and 
resources to do all that they are doing is an ongoing struggle and they rarely become involved in 
starting new companies or transforming existing ones very far from where they are doing the rest 
of their work.  Therefore, the geographies of technological progress and star scientists tend to 
coincide.  In this section we will consider where the stars begin their professional careers, change 
regions or locations of residence and/or enter new scientific fields.  
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Economic geography provides us with the useful concepts of agglomeration and 
diffusion, which are two sides of the same coin.  Agglomeration occurs with respect to a 
particular measure of interest if concentration is increasing over time: regions or countries with 
larger values of this measure have disproportionately high growth rates for the same measure 
while those with lower values have disproportionately low growth rates.  High-technology 
industries, for example, tend to concentrate over time or agglomerate in a relatively few centers, 
and knowledge in a specialty or subspecialty tends to grow faster in centers which have achieved 
a ‘critical mass’ of scholars (Zucker, Darby, Furner, Liu and Ma 2007).  Diffusion is the mirror 
image of agglomeration: regions or countries with smaller values have disproportionately high 
growth rates for the measure being considered while those with higher values have 
disproportionately low growth rates.  Diffusion is the goal of many economic development 
schemes, notably in the European Union, as well as a natural process for the spread of 
knowledge. 
The correlation coefficient of the level and growth rate of a variable measured across 
regions or countries and over time is a direct index of agglomeration or diffusion.  If the 
correlation coefficient (which ranges from -1 to 1) is positive, the variable is agglomerating 
while a negative correlation coefficient shows that the variable is diffusing over time.  In Table 
2, adapted from Table 5 in Zucker and Darby (2007c) and Table 8 in Zucker and Darby (2006), 
we present these correlation coefficients for a number of variables of interest and for different 
sets of countries.  Whether we look at US regions or any of the listed combinations of the top-25 
S&T countries in the world, university article publication is diffusing, with traditionally weaker 
regions and countries tending to catch up with traditional scientific leaders.  This suggests that 
more regions and countries will over time provide a fertile ground for new star scientists to  
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emerge where before it would be very difficult.  This observation is confirmed – but more 
weakly – by the tendency for high impact articles (those that are very highly cited by other 
scientists) to diffuse, although that diffusion is statistically significant only where the US is not 
included in the set of countries. 
The third line for each geographical comparison tells us that firm entry is in fact 
agglomerating across the gamut of broad high-technologies both across US regions and across 
the non-OECD [developing] countries among the top-25 S&T countries.  On the other hand, this 
tendency toward concentration of broad high-technologies is not statistically significant or 
nonexistent for the geographic comparisons including 18 (without US) or 19 (with US) of the 
OECD [developed] countries.  Whether or not high-technology firm entry is agglomerating 
seems to be determined in substantial part by whether or not star scientists are agglomerating, 
with that tendency is strongest across US regions and across the non-OECD countries among the 
top-25 S&T countries.  Star scientists entry shows strong agglomeration and tends to drive 
agglomeration of the number of star scientists resident in a region or country unless offset by 
migration (Zucker and Darby 2007c). 
Overlaying this pattern during the last quarter century, however, are movements of many 
US trained foreign students who build successful careers in American academe, perhaps moving 
from lower to higher ranked US universities but choose to return home when their native 
countries develop sufficient strength in their disciplines to both seek them out and to be attractive 
(Saxenian 2005).  This weakens the tendency toward concentration when the US is in the country 
data set, but not when it is out.  Since this effect is present to a somewhat similar degree in all 
American universities, the reverse brain drain of expatriate stars affects the average growth rate 
of stars in the US without weakening the positive correlation across countries.  
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Table 3, from Table 6 in Zucker and Darby (2007c), presents novel evidence on the 
location and migration of star scientists and engineers among the top-25 S&T countries.  About 
93 percent of the world’s star scientists and engineers in the world have residences in the top-25 
S&T countries at the end of 2004 – 62 percent in the US alone.
8  It should be noted that non-US 
scientists suspect that ISI citation measures and therefore the ISI Highly Cited are inherently 
biased in favor of English-speaking and particularly American scientists (and, in fact, there must 
be published English translations of titles and abstracts for a non-English language to be ISI-
listed).  The dominant factor determining the number of stars resident in a country at the end of 
the period or at any time during the period is the number of professional debuts made in the 
country.  Future stars are more likely to get their first job where they want to live and they tend 
to stay there.  However, migration does make a difference for some countries and losing even 
one or two dominant firms founded by emigrants to other countries can be a significant 
economic event. 
Table 3 shows clear evidence of reversal of the traditional brain drain from other 
countries, particularly less developed ones, to the US and other science powerhouses like Britain 
and Germany.  The four largest net immigrations of star scientists over the last quarter century 
were registered by the United Kingdom (-27 or 4.6 percent of all stars resident in the country at 
any time 1981-2004), the United States (-23 or 0.6 percent), Canada (-23 or 7.7 percent) and 
Germany (-11 or 3.0 percent).  Recall that Table 1 showed that for biotechnology stars (defined 
by genetic-sequence discoveries, not citations) 1973-1989, the US and Germany had inward net 




For the six developing countries near the bottom of Table 3, round-trip inward migration 
(where a star moves there for more than two years but later leaves) provides a significant source 
of brain power and innovation accounting for from 33 to 79 percent of all star scientists ever 
resident in those countries, 1981-2004.  Moreover, about 20 percent of all inward migrant stars to 
these countries had not returned as of 2004, mostly due to those remaining in China and Taiwan. 
At this point we read the evidence on migration of stars as cautionary for the US, but 
alarming for some other countries (such as Canada, Germany, Israel and the United Kingdom).  
We also see hope for some developing countries that inward migration (frequently of native 
born, foreign-educated stars) can provide an important supplement to home-grown stars if 
working and living conditions are right to attract and retain them (Zucker and Darby 2007c). 
 
IV. Conclusions 
  From the bare economic point of view the importance of geniuses is only 
beginning to be appreciated.  How can we measure the cash-value to France of a Pasteur, 
to England of a Kelvin, to Germany of an Ostwald, to us here of a Burbank? One main 
care of every country in the future ought to be to find out who its first rate thinkers are 
and to help them. Cost here becomes, irrelevant, the returns are sure to be so 
incommensurable. 
     -  William  James  (1911,  pp.  363-364) 
 
William James – the father of American psychology and a first rate thinker – apparently 
foresaw the extraordinarily high estimates of the return current in the economics of S&T 
literature and perhaps the coming of the National Science Foundation, the National Institutes of 
Health and their sister institutions in the US and other countries.  However, democratic values 
largely trumped the study – much less appreciation or even mention – of geniuses as a politically 
incorrect vestige of the ‘great man theory’ which should be consigned to the dustbin of history.   
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It is only the accumulation of stubborn facts that has persuaded us that this view is fundamentally 
wrong so far as it comes to understanding innovation. 
Innovation is mostly not about the accumulation of small changes – inching up as the 
Japanese would have it – but about the rare occurrence of very large improvements in how to do 
things or what can be done.  Inching up may be better done by 100 journeyman engineers than 1 
or 2 scientific geniuses but great innovations are much more likely to come from the geniuses. 
The star scientists in this paper are remarkably energetic, and when they see that one of 
their discoveries has substantial commercial value and the incentives (including funding more 
research) are right, they find a way to sell their idea to an existing firm or create a new one to 
commercialize it.  They are opportunists in the best senses of the word: creating opportunity, 
seeing it where others do not and carrying forward with a drive that gets things accomplished 
despite an already overfull agenda.  James calls on the government to help them, but often it is 
enough to simply stay out of their way.  They are quite used to helping themselves and smart 
enough to speak of team work, generally relying on small teams of extraordinary scientists or 
scientists-in-training (Zuckerman 1977). 
The American system of research universities has been remarkably effective in providing 
a flexible home base for star innovators to work from.  For decades America attracted the best 
and brightest from around the world to come for a doctoral education.  The very best of these 
often never left, contributing to US growth.  A century and a half ago Germany benefited from 
its similar role as the center of science.  James included among his four exemplars of genius with 
obviously great cash value Wilhelm Ostwald (1853-1932), the 1909 Nobel Laureate for 
Chemistry for his work on catalytic reactions and Professor of Physical Chemistry at Leipzig 
University in Germany 1887-1906.  In the commercial realm, the Ostwald process for producing  
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nitric acid remains a mainstay of the modern chemical industry.  We should note that Ostwald, a 
native of Riga, Latvia, was also an exemplar of the value of brain drain to the receiving country. 
Our earlier research has shown the importance of star scientists in their commercial role 
of star innovators creating the dominant firms in important industries driven by rapid scientific 
progress.  Our results on firm entry suggest that this is true across the broad range of high-
technology industries.  The individuals at the very top of their scientific discipline are the ones 
most likely to fundamentally change how things are done in their science and in its commercial 
applications.  America has profited greatly from providing a seed bed for producing and 
retaining most of these people for the last sixty years.  There is evidence that recent policy 
changes such as on student visas have endangered that privileged status.  It would be a very 





1 Baumol, Litan and Schramm (2007) argue persuasively that both small entrepreneurial firms and 
large dominant firms play important roles in growth and prosperity.  Darby and Zucker (2006) argue 
that the prospect of a small entrepreneurial firm’s becoming a large dominant firm provides part of 
the incentive to bear the costs of turning a great idea into a commercial innovation in a startup firm. 
2  This market-based model is an alternative – and empirically superior as discussed below – 
explanation for clustering of high-tech industries around universities to positive externalities (such 
as quicker knowledge diffusion through attending seminars) as advocated Jaffe (1986), Dorfman 
(1988), Jaffe, Trajtenberg and Henderson (1993), Bania and Fogarty (1993), and Saxenian (1996).  
It also differs from the Crane (1969, 1972) invisible colleges view in which geography and bench-
science interaction have vanishing importance. 
3 These knowledge spillovers play a central role in the economics literature as causes of geographic 
agglomeration (local concentration) of particular industries and of endogenous growth in the ‘New 
Growth Theory Models’ (Romer 1986, 1990; Grossman and Helpman 1991; Eaton and Kortum 
1996, 1999; Jones 1995) though the empirical search for their existence has proved difficult 
(Griliches 1992).  Demonstration of statistically significant positive effects on a firm's productivity 
of being near great universities and other sources of scientific discovery also have been taken as 
fingerprints of such spillovers by Acs and Audretsch 1988 and 1993, Acs, Audretsch, and Feldman 
1994, and Mansfield 1995. 
4 The stars’ contributions to open science are measured in Zucker and Darby (2007a) by the 
number of articles published per year, given that the citations per article increase in the US and 
are insignificantly different in Japan. 
5 The US Bureau of Economic Analysis defines the 179 regions as functional economic areas such  
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that each US county is assigned to a region which includes the major metropolitan center for which 
commuting, shopping, and newspaper readership predominates (Johnson and Kort 2004).  The 25 
countries are: Australia, Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, 
Israel, India, Italy, Japan, Germany, the Netherlands, Norway, Poland, South Korea, Spain, 
Sweden, Switzerland, Taiwan, the United Kingdom, the United States, and the USSR & Russia 
counted as the same country. 
6 The curriculum vitae supplied to ISI author appears to be in an abbreviated (apparently NSF or 
NIH) format for 41.0 percent of these stars, with 37.8% reporting exactly 10 ISI articles and 3.2 
percent reporting 5-9 ISI articles.  Since the NSF and NIH formats impose strict 10-publications 
and 1-3 pages limits (the latter depending on the grant program), listed publications and 
affiliations are chosen strategically to enhance the odds of funding.  Less prestigious, especially 
commercial, affiliations are also not infrequently omitted from full academic curricula vitae so 
we chose to identify location by those listed at the time of publication of articles rather than rely 
on the ones reported retrospectively. 
7 ISI article data do not distinguish which address (normally an organization) goes with which 
author except for a possible single author designated corresponding author who then matches (at 
least) to the corresponding address).  The cases indicated in the text are those for which the star 
scientist can be definitively located with an address because they are the corresponding author, 
the sole author, or there is only 1 listed corresponding or research address for a journal that 
reports multiple addresses on other articles in the same year.  The 299,583 authorships 
corresponded to 276,182 different articles, with the difference (23,401) all accounted for by 
multiple star authors on articles with a single address. 
8 A small number of the stars have residences in two countries, judging from their publications  
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and patents, and a handful made their professional debut simultaneously in two countries, 
presumably reflecting the locations of their doctoral work and first job. 
9 On the other hand, the United Kingdom and Canada had large outward migration rates in Table 
1 (32.3 and 30.0 percent, respectively) so those countries were already experiencing a brain 
drain.  Switzerland reversed its direction in a favorable direction for that country between the 
two tables.  
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Star Bioscientists, Their Ties to Firms and Migration Rates 
Top-10 Countries, 1973-1989 
 
 
Countries             Share of        Fraction       Migration Rate__ 
    s t a r s
a        tied to firms
b Gross
c   Net
d 
 
United  States    50.2   33.3   22.2     2.9 
Japan     12.6   42.3   40.4     9.6 
United Kingdom      7.5      9.7    58.1           -32.3 
France         6.1      0.0    20.0     4.0 
Germany         5.8      0.0    50.0     8.3 
Switzerland        3.6    20.0    93.3           -40.0 
Australia         3.4      7.1    35.7       7.1 
Canada         2.4      0.0    50.0           -30.0 
Belgium         1.7    14.2    42.9            14.3 
Netherlands           1.2   20.0   80.0     0.0 
 
Total  for  top  10   94.7   14.9   35.4   -0.8 
 
 
Source: Adapted from Zucker and Darby (1999b), Table 1. 
Notes:  a. Total stars ever publishing a genetic-sequence discovery article 1973-1989 in this country as a 
percentage of total stars ever such an article 1973-1989 in any country. This involves some 
double-counting of multiple-country stars.  Countries in the omitted rest of world with any stars are 
Denmark, Finland, Israel, Italy, Sweden and the USSR. 
  b. Percentage of stars ever publishing a genetic-sequence discovery article 1973-1989 in the country 
that ever published such an article in which the star or a coauthor was affiliated with a firm in the 
country. 
  c. Gross migration rate = 100 x (immigration + emigration of stars)/(number of stars ever publishing 
in the country) 





Agglomeration or Diffusion? Correlation Coefficients for the Levels and Growth Rates of 
Articles, Firm Entry and Star Scientists & Engineers 
 
Bio/Chem/Med Computing/IT Nanotechnology Semiconductors Other Sciences Other Engineering
US Regions
University Articles
b -0.07** -0.08** -0.09** -0.08** -0.04^ -0.04^
High Impact Articles
b -0.02 -0.04 -0.03 -0.03 -0.03 -0.04
Firm Entry 0.09*** 0.16*** 0.22*** 0.20*** 0.17*** 0.04*
Star Scientists & Engineers 0.04^ 0.08** 0.19*** 0.07** 0.11*** 0.19***
Star Scientist Entry 0.29*** 0.53*** 0.85*** 0.60*** 0.73*** 0.73***
Top-25 S&T Countries
University Articles
b -0.16*** -0.18*** -0.18*** -0.21*** -0.08* -0.16***
High Impact Articles
b -0.08^ -0.06 -0.08 -0.05 -0.05 -0.05
Firm Entry -0.04 -0.01 0.00 -0.02 -0.02 -0.04
Star Scientists & Engineers -0.05 0.04 -0.01 0.00 0.02 0.01
Star Scientist Entry 0.01 0.12* 0.53*** 0.13* 0.18** 0.28***
Top-24 Non-US S&T Countries
University Articles
b -0.29*** -0.29*** -0.23*** -0.27*** -0.15*** -0.26***
High Impact Articles
b -0.15*** -0.01 -0.13* -0.09* -0.11* -0.09^
Firm Entry -0.03 0.10* 0.10^ 0.05 0.06 -0.05
Star Scientists & Engineers -0.06 0.04 0.20*** 0.08^ 0.08 0.17**
Star Scientist Entry 0.19*** 0.73*** 0.93*** 0.64*** 0.73*** 0.83***
Non - OECD Countries:
University Articles
b -0.42*** -0.18* -0.16^ -0.32*** -0.19* -0.39***
High Impact Articles
b -0.10 0.22** -0.08 -0.12 -0.11 -0.12
Firm Entry 0.13 0.28** 0.45*** 0.29** 0.42*** 0.03
Star Scientists & Engineers 0.00 0.05 0.67*** 0.31*** 0.75*** 0.42***
Star Scientist Entry 0.65*** 0.84*** 0.90*** 0.83*** 0.96*** 0.95***
OECD Countries (Including US)
University Articles
b -0.16*** -0.20*** -0.19*** -0.21*** -0.17*** -0.16***
High Impact Articles
b -0.08^ -0.07 -0.09 -0.08^ -0.06 -0.05
Firm Entry -0.05 -0.01 0.00 -0.02 -0.03 -0.04
Star Scientists & Engineers -0.02 0.06 -0.02 0.00 -0.01 0.00
Star Scientist Entry 0.00 0.13* 0.52*** 0.13* 0.17* 0.25**
OECD Countries (Excluding US)
University Articles
b -0.3*** -0.32*** -0.24*** -0.26*** -0.29*** -0.24***
High Impact Articles
b -0.17*** -0.03 -0.15* -0.14** -0.12* -0.09^
Firm Entry -0.03 0.08 0.09 0.07 0.04 -0.05
Star Scientists & Engineers -0.02 0.06 0.19** 0.07 0.02 0.15*
Star Scientist Entry 0.19*** 0.72*** 0.94*** 0.63*** 0.72*** 0.81***
Notes:   Significance levels:  ^ 0.10, * 0.05, ** 0.01, ***0.001
a. The science and engineering areas are Biology/Chemistry/Medicine; Computing & Information Technology; 
Semiconductors, Integrated Circuits & Superconductors; Nanoscale Science & Technology; Other Sciences; and Other 
Engineering.  Nanoscale Science & Technology articles and patents as defined for NanoBank.org are removed from the 
other five areas into which they would otherwise be classified.
b. University and high impact articles are measured as knowledge stocks computed as perpetual inventories with the input
series the current year's publication of all university or high impact articles, respectively, and the depreciation rate set at
20 percent per year.  These variables were among those used in the analysis of firm entry and accordingly articles with
authors affiliated with firms were excluded in counting the input series.





Star Scientists’ Professional Debuts and Migration Rates 
Top-25 Science and Technology Countries, 1981-2004 
 












Austria 14 6 1 2 20 -4 10 36
Belgium 37 7 1 2 15 -5 32 54
Denmark 29 5 3 5 15 0 29 49
Finland 14 2 1 0 7 -2 12 20
France 135 20 19 22 114 2 137 265
Germany 222 35 17 24 123 -11 211 362
Italy 60 14 11 16 47 2 62 120
Netherlands 78 10 4 8 30 -2 76 115
Norway 12 2 1 3 13 1 13 27
Poland 6 4 3 1 15 -3 3 22
Spain 13 1 1 8 29 7 20 49
Sweden 70 12 7 5 40 -7 63 112
Switzerland 80 17 7 27 45 10 90 148
United Kingdom 424 70 31 43 122 -27 397 581
Europe
a 1194 205 107 166 635 -39 1155 1960
APEC Member Countries
Non-U.S. APEC Countries
Australia 97 15 10 25 49 10 107 170
Canada 201 51 13 28 72 -23 178 300
Japan 176 5 15 18 76 13 189 266
South Korea 1 0 0 4 7 4 5 12
Non-U.S. APEC
a 475 71 38 75 204 4 479 748
United States 3354 142 276 119 216 -23 3331 3670
APEC Countries
a 3829 213 314 194 420 -19 3810 4418
OECD Member Countries
a 5023 418 421 360 1055 -58 4965 6378
OECD Nonmember Countries
Brazil 1 1 0 3 15 2 3 19
China 4 1 0 11 26 10 14 39
India 10 3 1 3 14 0 10 27
Israel 57 13 5 4 28 -9 48 86
Russia/USSR 7 4 0 4 27 0 7 36
Taiwan 3 1 0 5 6 4 7 14
OECD Nonmember Countries
a 82 23 6 30 116 7 89 221
Top-25 S&T Countries
a 5105 441 427 390 1171 -51 5054 6599
Top-24 Non-U.S. S&T Countries
a 1751 299 151 271 955 -28 1723 2929
Source: Zucker and Darby (2007c)
Notes: a. Totals of individual country values have not been adjusted for doublecounting due to within-region migration.
b. Each person who publishes or patents giving an address in the country the first year that person publishes or patents 
anywhere is counted as making a professional debut in the country.  It is possible for one star to make a professional 
debut in more than one country and in a country other than the country of his or her birth or citizenship.
c. One-way immigration refers to the person stopping publishing or patenting in a country where they had been doing so
and starting doing that in another country with no subsequent return to the first country.  "Visits" of 2 years or less do
not count for inward or outward migration.
d. Round-trip immigration refers to the person stopping publishing or patenting in a country where they had been doing so
and starting doing that in another country and subsequently returning to the first country.  "Visits" of 2 years or less do
not count for inward or outward migration.
e. Net inward migration is one-way inward migration minus one-way outward migration.  Round-trip inward and outward 
migration leave the stock of stars unchanged.
f. The net stock of stars is the number making professional debuts in the country plus one-way inward migration minus
one-way outward migration, with no adjustment for death or retirement due to lack of information on when that occurs.
g. Unique persons is a count of the number of stars who have ever published or patented with an address in the country.
Outward Migration Inward Migration
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Figure 1. Estimated Effects of Number of University Star-Firm Linked Articles on Success of  
Californian and Japanese Biotechnology-Using Firms 
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Sources: Zucker, Darby and Armstrong (1998) for 
California and Zucker and Darby (2001) for Japan 
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Figure 2. Success of US Biotech by Ties to Star Scientists, Links to Top-112-Research-University Faculty,  
and Venture-Capital Funding Levels 
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Source: Zucker, Darby and 
Armstrong (2002) 
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Source: Zucker and Darby (2006) 
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Source: Zucker and Darby (2006) 
36 




Source: Zucker and Darby (2006) 
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Figure 6. Nanoscale Science and Technology Star Scientists & Firm Entry, 25 Countries, 1981-2004 
 
 
Source: Zucker and Darby (2006) 
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Figure 7.  Star Scientists and Engineers Increase the Probability of Firm Entry into New Technologies 
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Active Stars = 1 Active Stars = Mean Active Stars = Mean + 1 Standard Deviation Active Stars = Mean + 2 Standard Deviations
Estimates based on 179 U.S. 
functional economic regions
Estimates based on top-24 
S&T nations excluding U.S.A
Source: Zucker and Darby (2006) 
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Figure 8.  Star Scientists and Engineers Increase the Probability of Firm Entry into New Technologies 
Stars Defined as First 1,838 (First 34%) in ISI HighlyCited
SM 
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Active Stars = 1 Active Stars = Mean Active Stars = Mean + 1 Standard Deviation Active Stars = Mean + 2 Standard Deviations
Estimates based on 179 U.S. 
functional economic regions
Estimates based on top-24 
S&T nations excluding U.S.A
Source: Zucker and Darby (2006)